Hester Biosciences Ltd.

₹2,198.4

31.4 (1.4%)

HESTERBIO Share Price

Pharmaceuticals & Biotechnology

As on July 3, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,870 Cr

P/E Ratio33.61

Dividend Yield0.05 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	2,185.7	Bullish
10-DMA	2,174.13	Bullish
20-DMA	2,084.64	Bullish
50-DMA	1,897.78	Bullish
100-DMA	1,686.44	Bullish
200-DMA	1,680.48	Bullish

Historical Performance

1 Year

21.5%

3 Years

29.2%

5 Years

-14.8%

10 Years

198.8%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	3,326	3,111	3,045	2,661	2,350
Total Expenditure	2,507	2,500	2,514	2,157	1,750
Other Income	144	39	111	154	137
Operating Profit	963	650	643	658	737
Interest	109	127	198	93	41
Depreciation	189	168	172	207	166
Profit Before Tax	758	396	320	402	535
Consolidated Net Profit	556	275	189	266	393
Adjusted EPS	65	32	22	31	46

Compounded Sales Growth

10 Years:26.9

5 Years:9.2

3 Years:4.6

TTM:1.3

Compounded Profit Growth

10 Years:23.7

5 Years:10.1

3 Years:15.9

TTM:15.1

Stock Price CAGR

10 Years:11.6

5 Years:-2.9

3 Years:8.4

TTM:22.4

Return on Equity

10 Years:27.7

5 Years:46.2

3 Years:22.2

last year:65.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	85	85	85	85	85
Total Reserves	3,517	3,057	2,833	2,712	2,515
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	1,577	2,015	2,540	2,327	1,979
Other Current Liabilities	970	611	450	560	428
Short Term Borrowings	243	296	314	589	348
Total Liabilities	6,779	6,534	6,623	6,700	5,622
Capital Work in Progress	---	1,767	1,681	1,461	802
Long Term Loans & Advances	55	65	56	77	242
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	271	369	393	423	337
Total Current Assets	2,086	1,952	2,146	2,276	1,948
Total Assets	6,779	6,534	6,623	6,700	5,622
Adjusted Book Value	423	369	343	329	306

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 33.61, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a moderate 3-year price CAGR of 8.4%, reflecting average market performance.
The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹963 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹3326 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1231458.7

No. of Shares: 560 (Approx)

Performance:23.1%

P/L: ₹231458.7

NIFTY Performance: -4.7%

1 day Top Gainers